Diabetes Mellitus, Type 1: all 3,614 studies

Page 12 of 37. Open to participants first (585), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal HyperfiltrationCompletedNCT01392560Phase 2Results posted
• Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range SystemCompletedNCT01390259Not applicableResults posted
• The Relationship of Hemoglobin A1c and Diabetic Wound HealingTerminatedNCT01350102Phase 4Results posted
• Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet TransplantationCompletedNCT01346085Phase 1/2Results posted
• Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 DiabetesCompletedNCT01280682Phase 4Results posted
• Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT01275131Phase 1Results posted
• Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell RecoveryCompletedNCT01272583Not applicableResults posted
• Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaCompletedNCT01269047Phase 4Results posted
• New Onset Type 1 Diabetes: Role of ExenatideCompletedNCT01269034Phase 4Results posted
• Effects of Metreleptin in Type 1 Diabetes MellitusTerminatedNCT01268644Phase 1Results posted
• United Kingdom User Evaluation, MiniMed Paradigm® X54 SystemCompletedNCT01267175Phase 4Results posted
• Real-time Adaptation to Changes in Insulin SensitivityCompletedNCT01261052Phase 2Results posted
• Statins in Children With Type 1 Diabetes and HypercholesterolemiaCompletedNCT01236365Phase 3Results posted
• Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesCompletedNCT01231984Not applicableResults posted
• Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes MellitusTerminatedNCT01222078Phase 2Results posted
• Reparixin in Pancreatic Islet TransplantationCompletedNCT01220856Phase 2Results posted
• Evaluation of a Treatment and Education Programme for Type 1 Diabetic Patients (PRIMAS)CompletedNCT01220557Not applicableResults posted
• T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal TregsCompletedNCT01210664Phase 1Results posted
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTerminatedNCT01206101Phase 2Results posted
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.CompletedNCT01194479Not applicableResults posted
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusCompletedNCT01194245Phase 2Results posted
• A Research Trial of Aralast in New Onset Diabetes (RETAIN)TerminatedNCT01183468Phase 1Results posted
• New Glucose Sensor PediatricCompletedNCT01161043Not applicableResults posted
• Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 DiabetesCompletedNCT01155284Phase 2Results posted
• Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 SystemCompletedNCT01148862Not applicableResults posted
• Continuous Glucose Monitoring to Measure Effect of Glycemic IndexCompletedNCT01145547Not applicableResults posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01134107Phase 3Results posted
• Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2CompletedNCT01123083Phase 3Results posted
• Diabetes Prevention - Immune ToleranceCompletedNCT01122446Phase 2Results posted
• An Inpatient Performance Evaluation of a New Subcutaneous Glucose SensorCompletedNCT01112696Not applicableResults posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01109316Phase 3Results posted
• Reversing Type 1 Diabetes After it is EstablishedCompletedNCT01106157Phase 1/2Results posted
• Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsCompletedNCT01103284Phase 3Results posted
• Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin TreatmentCompletedNCT01099618Phase 4Results posted
• Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With DiabetesCompletedNCT01083433Not applicableResults posted
• Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesCompletedNCT01079234Phase 3Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT01074268Phase 3Results posted
• Naltrexone and Hypoglycemia in Type 1 DiabetesCompletedNCT01053078Phase 1/2Results posted
• A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"CompletedNCT01030861Phase 2Results posted
• Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin RequirementsCompletedNCT01029392Phase 3Results posted
• Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)CompletedNCT01019486Phase 4Results posted
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCompletedNCT00993473Phase 3Results posted
• A Study on the Effect of 2 Pen Devices on HbA1cCompletedNCT00985712Phase 4Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00982228Phase 3Results posted
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00978627Phase 3Results posted
• Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)CompletedNCT00977808Not applicableResults posted
• Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal HypoglycemiaCompletedNCT00974051Not applicableResults posted
• Inducing Remission in Type 1 Diabetes With AlefaceptTerminatedNCT00965458Phase 2Results posted
• Canakinumab Study in Individuals With Newly Diagnosed Type 1 DiabetesCompletedNCT00947427Phase 2Results posted
• Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic ControlCompletedNCT00945659Not applicableResults posted
• Counter-Regulatory Impairment and the Effect of Microvascular Insulin Transfer in Type 1 Diabetes MellitusCompletedNCT00943787Not applicableResults posted
• Comparison of Glycemic Control Among Diabetics Using Three Different Pen NeedlesCompletedNCT00928057Not applicableResults posted
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes MellitusTerminatedNCT00920582Phase 3Results posted
• The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenCompletedNCT00913497Phase 4Results posted
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 DiabetesTerminatedNCT00891995Phase 2/3Results posted
• Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant RecipientsCompletedNCT00888628Phase 1/2Results posted
• Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop StudyCompletedNCT00884611Not applicableResults posted
• Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusCompletedNCT00883558Phase 2Results posted
• Effect of Diabetes Mellitus on Cholesterol MetabolismCompletedNCT00879710Not applicableResults posted
• Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)TerminatedNCT00870818Not applicableResults posted
• Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 DiabetesTerminatedNCT00869414Not applicableResults posted
• Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study ACompletedNCT00858897Not applicableResults posted
• Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study BCompletedNCT00858273Not applicableResults posted
• Pramlintide in Adolescents With Type 1 DiabetesCompletedNCT00842075Not applicableResults posted
• Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT00841087Phase 2Results posted
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesTerminatedNCT00837759Phase 2Results posted
• Insulin Delivery Using Microneedles in Type 1 DiabetesCompletedNCT00837512Phase 2/3Results posted
• Effect of Closed Loop Glucose Control on Exercise-Associated HypoglycemiaCompletedNCT00831389Not applicableResults posted
• Closed-loop Glucose Control for Automated Management of Type 1 DiabetesCompletedNCT00811317Not applicableResults posted
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin AloneCompletedNCT00797823Phase 2Results posted
• The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic PatientsTerminatedNCT00791076Phase 2Results posted
• INTERPRET - International Report on Routine Practice of Sensor-enabled Pump TherapyCompletedNCT00790088Results posted
• Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal TransplantCompletedNCT00788827Phase 1Results posted
• Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 TeslaCompletedNCT00786825Phase 2Results posted
• Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes MellitusCompletedNCT00774800Phase 2Results posted
• Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsCompletedNCT00773279Phase 3Results posted
• Incretin Effect and Use After Clinical Islet TransplantationCompletedNCT00768651Phase 2Results posted
• Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DMCompletedNCT00760526Phase 3Results posted
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate IntakeTerminatedNCT00747006Phase 2Results posted
• Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood GlucoseCompletedNCT00741390Not applicableResults posted
• PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)TerminatedNCT00729365Phase 3Results posted
• Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 DiabetesCompletedNCT00727220Results posted
• Continuous Glucose Sensor Profiles in Non-Diabetic SubjectsCompletedNCT00717977Phase 4Results posted
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-WeeksTerminatedNCT00700622Phase 3Results posted
• Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn PhenomenonCompletedNCT00694122Phase 3Results posted
• Efficacy of Lubiprostone in Combination With Standard PEG PreparationTerminatedNCT00689026Not applicableResults posted
• Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) ProtocolActive, not recruitingNCT00679042Phase 3Results posted
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1CompletedNCT00678886Phase 3Results posted
• Raptiva and Sirolimus in Islet Transplantation for Type 1 DiabetesTerminatedNCT00672204Phase 1/2Results posted
• A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin LisproCompletedNCT00662857Phase 2Results posted
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00659295Results posted
• Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 DiabetesCompletedNCT00645840Phase 1/2Results posted
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted
• Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689CompletedNCT00623194Phase 3Results posted
• Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes PatientsCompletedNCT00615264Phase 3Results posted
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT00612040Phase 2Results posted
• Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes MellitusCompletedNCT00607087Phase 4Results posted
• Mobile Communication Technology for Adolescents With DiabetesCompletedNCT00605839Not applicableResults posted
• SWITCH - Sensing With Insulin Pump Therapy to Control HbA1cCompletedNCT00598663Not applicableResults posted

← Diabetes Mellitus, Type 1 overview